Neuromodulation

Neuromodulation holds promising therapeutic potential for Alzheimer's Disease and dementia by targeting brain circuits involved in cognitive decline. This approach involves techniques such as deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS). DBS, for instance, targets specific brain regions to regulate abnormal neural activity linked to memory loss and cognitive impairment. TMS utilizes magnetic fields to stimulate nerve cells, potentially enhancing cognitive functions. tDCS delivers low-intensity electrical currents to modulate brain activity, aiming to improve cognitive abilities. These methods aim to alleviate symptoms and slow disease progression by directly influencing neural pathways implicated in Alzheimer's and dementia. Ongoing research focuses on optimizing these techniques, exploring their long-term efficacy, and expanding their application to offer new hope in managing and treating these challenging neurodegenerative conditions.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France

Submit your abstract Today

Whatsapp